To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
118th Congress: House Bill No. 3839
Introduced on June 6, 2023
June 6, 2023 Referred to a Committee
Try searching for...
Introduced on June 6, 2023
June 6, 2023 Referred to a Committee